SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/9B480AEECCCF2527A94F50BDA9364ED8F9B0CEA673B1610C104CFEF450C944B63FB0C6A227B8CA26A873586929B47988>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/9B480AEECCCF2527A94F50BDA9364ED8F9B0CEA673B1610C104CFEF450C944B63FB0C6A227B8CA26A873586929B47988
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/9B480AEECCCF2527A94F50BDA9364ED8F9B0CEA673B1610C104CFEF450C944B63FB0C6A227B8CA26A873586929B47988
http://www.w3.org/2000/01/rdf-schema#comment
"Results indicate that CT16 promotes the survival of melanoma cells and is therefore a potential target for future drug development."
xsd:string
http://purl.uniprot.org/uniprot/#_D8D9298AC40B3CA206180A16D6193CA50C0C9E16D487301752347F082CA9FAFA26813642A1ED2BFF5D3177B7C353BF02
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/9B480AEECCCF2527A94F50BDA9364ED8F9B0CEA673B1610C104CFEF450C944B63FB0C6A227B8CA26A873586929B47988
http://purl.uniprot.org/uniprot/Q96GU1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/9B480AEECCCF2527A94F50BDA9364ED8F9B0CEA673B1610C104CFEF450C944B63FB0C6A227B8CA26A873586929B47988
http://purl.uniprot.org/uniprot/#_Q96GU1-mappedCitation-23028975
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/9B480AEECCCF2527A94F50BDA9364ED8F9B0CEA673B1610C104CFEF450C944B63FB0C6A227B8CA26A873586929B47988